Thurston Springer Miller Herd & Titak’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.62M Buy
38,358
+34,231
+829% +$6.2M 2.04% 5
2026
Q1
$607K Sell
4,127
-33,881
-89% -$5.51M 0.25% 107
2025
Q4
$7.41M Buy
38,008
+37,249
+4,908% +$8.87M 2.58% 6
2025
Q3
$213K Sell
759
-36,336
-98% -$9.25M 0.42% 64
2025
Q2
$8.11M Hold
37,095
1.05% 10
2025
Q1
$5.19M Buy
37,095
+312
+0.8% +$50.8K 0.87% 16
2024
Q4
$6.13M Buy
36,783
+183
+0.5% +$32.5K 1.24% 10
2024
Q3
$6.24M Sell
36,600
-237
-0.6% -$34.3K 1.72% 6
2024
Q2
$5.2M Buy
+36,837
New +$4.57M 1.62% 7

Other funds holding ORCL

Thurston Springer Miller Herd & Titak's ORCL Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Oracle (ORCL) stake by 829% in Q2 2026, buying an estimated $6.2M and bringing the position to 38,358 shares worth $5.62M. The position accounts for 2.04% of the portfolio, ranked #5.

Thurston Springer Miller Herd & Titak first reported a position in ORCL in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.11M in Q2 2025. 1,377 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 38,358 shares of Oracle worth $5.62M as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 34,231 Oracle shares in Q2 2026, an estimated $6.2M.
  • Oracle made up 2.04% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #5 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Oracle in Q2 2024 and has held it in 9 quarters since.
  • Thurston Springer Miller Herd & Titak's Oracle position peaked at $8.11M in Q2 2025.
  • 1,377 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.